Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


The metabolism of 25-hydroxycholesterol in different cell types was studied and the role of 7 alpha-hydroxylation for the effect of 25-hydroxycholesterol on the activity of HMG-CoA reductase was determined. Human diploid fibroblasts (HDF) and the human melanoma cell line SK-MEL-2 converted 25-hydroxycholesterol into 7 alpha,25-dihydroxycholesterol and 7 alpha,25-dihydroxy-4-cholesten-3-one while the virus-transformed fibroblast line 90VA-VI, the colon carcinoma cell line WiDr and the breast cancer cell line MDA-231 did not express 7 alpha-hydroxylase activity. The 7 alpha-hydroxylation of 25-hydroxycholesterol in HDF could be stimulated by dexamethasone and cortisol and inhibited by metyrapone. An unidentified, possibly 4-hydroxylated, metabolite was formed by 90VA-VI cells and a polar, probably conjugated, metabolite was formed by WiDr cells. The 7 alpha-hydroxylated metabolites of 25-hydroxycholesterol suppressed the activity of HMG-CoA reductase to a similar extent as 25-hydroxycholesterol in HDF but not in 90VA-VI cells, while the 7 alpha-hydroxylated metabolites of 27-hydroxycholesterol suppressed the activity of HMG-CoA reductase also in 90VA-VI cells. The suppression of HMG-CoA reductase activity by 25- and 27-hydroxycholesterol was decreased or abolished by dehydroepiandrosterone or pregnenolone which have little or no effect on the 7 alpha-hydroxylation. The results indicate that 7 alpha-hydroxylation is not directly involved, positively or negatively, in the action of 25- or 27-hydroxycholesterol as suppressors of HMG-CoA reductase activity.

References 


Articles referenced by this article (45)

  • Smith, L.L. and Johnson, B.H. (1989) Free Radic. Biol. Med. 7, 285–332.

  • Andersson, S., Davis, D.L., Dahlbäck, H., Jörnvall, H. and Russell, D.W. (1989) J. Biol. Chem. 264, 8222–8229.

  • Skrede, S., Björkhem, I., Kvittingen, E.A., Buchmann, M.S., Lie, S.O., East, C. and Grundy, S. (1986) J. Clin. Invest. 78, 729–735.

  • Pedersen, J.I., Oftebro, H. and Björkhem, I. (1989) Biochem. Int. 18, 615–622.

  • Cali, J.I. and Russell, D.W. (1991) J. Biol. Chem. 266, 7774–7778.

  • Axelson, M., Shoda, J., Sjövall, J., Toll, A. and Wikvall, K. (1992) J. Biol. Chem. 267, 1701–1704.

  • Toll, A., Shoda, J., Axlson, M., Sjövall, J. and Wikvall, K. (1992) FEBS Lett. 296, 73–76.

  • Shoda, J., Toll, A., Axelson, M., Pieper, F., Wikvall, K. and Sjövall, J. (1993) Hepatology 17, 395–403.

  • Björkhem, I., Nyberg, B. and Einarsson, K. (1992) Biochim. Biophys. Acta 1128, 73–76.

  • Martin, K.O., Budai, K. and Javitt, N.B. (1993) J. Lipid Res. 34, 581–588.

Show 10 more references (10 of 45)

Citations & impact 


Impact metrics

Jump to Citations

Citations of article over time

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1016/s0005-2760(96)00148-8

Supporting
Mentioning
Contrasting
0
16
2

Article citations


Go to all (15) article citations